Please provide your email address to receive an email when new articles are posted on . Researchers produced an algorithm to standardize virtual myasthenia gravis assessments. More efforts are needed ...

Diagnosis of generalized myasthenia gravis involves clinical symptoms, serologic markers, and electrodiagnostic studies, with AChR and MuSK autoantibodies being key indicators. Differentiating ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

Ocular MG is a milder form of generalized MG, with lower AChR titers and less aggressive treatment needs. AChR titers above 100 nmol/L at diagnosis predict progression from ocular to generalized MG.

Mumbai doctors have successfully resolved a complex neurological case involving a 35-year-old nurse diagnosed with myasthenia gravis based on a positive antibody test and started on long-term ...

The United States Food and Drug Administration recently approved Uplizna ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) among adults who are antiacetylcholine receptor ...

After years of a therapeutic drought in generalized myasthenia gravis (gMG), new targeted therapies are finally providing options for rapidly effective and safe treatment. This rare autoimmune ...

Andrea Divis was shocked to learn that her symptoms of fatigue, blurred vision, and muscle weakness were due to a rare condition called myasthenia gravis. Here’s how she educated herself and took back ...